324 related articles for article (PubMed ID: 33302892)
21. Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough?
McMahon BA; Koyner JL
Adv Chronic Kidney Dis; 2016 May; 23(3):167-78. PubMed ID: 27113693
[TBL] [Abstract][Full Text] [Related]
22. Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients.
Shao M; Wang S; Parameswaran PK
Int Urol Nephrol; 2017 Feb; 49(2):295-302. PubMed ID: 27817055
[TBL] [Abstract][Full Text] [Related]
23. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
[TBL] [Abstract][Full Text] [Related]
24. Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study.
Ferrari F; Romero-González G; Topete LR; Senzolo M; Lorenzin A; Husain-Syed F; Puci MV; Ferraro OE; Muraro E; Serrano-Soto M; Triviño AM; Castro AC; Xie Y; Yang B; De Cal M; Corradi V; Brendolan A; Scarpa M; Carta MR; Giavarina D; Bonato R; Ronco C
Sci Rep; 2019 Nov; 9(1):16484. PubMed ID: 31712687
[TBL] [Abstract][Full Text] [Related]
25. Urinary [TIMP-2] × [IGFBP7] for risk prediction of acute kidney injury in decompensated heart failure.
Schanz M; Shi J; Wasser C; Alscher MD; Kimmel M
Clin Cardiol; 2017 Jul; 40(7):485-491. PubMed ID: 28295429
[TBL] [Abstract][Full Text] [Related]
26. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery.
Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X
BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Mortality and Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury.
Neyra JA; Ortiz-Soriano V; Liu LJ; Smith TD; Li X; Xie D; Adams-Huet B; Moe OW; Toto RD; Chen J
Am J Kidney Dis; 2023 Jan; 81(1):36-47. PubMed ID: 35868537
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index.
Garnier F; Daubin D; Larcher R; Bargnoux AS; Platon L; Brunot V; Aarab Y; Besnard N; Dupuy AM; Jung B; Cristol JP; Klouche K
Crit Care Med; 2020 Apr; 48(4):e277-e284. PubMed ID: 32205617
[TBL] [Abstract][Full Text] [Related]
29. Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.
Bai Z; Fang F; Xu Z; Lu C; Wang X; Chen J; Pan J; Wang J; Li Y
BMC Pediatr; 2018 Jun; 18(1):192. PubMed ID: 29907141
[TBL] [Abstract][Full Text] [Related]
30. Prediction of cardiac surgery associated - acute kidney injury (CSA-AKI) by healthcare professionals and urine cell cycle arrest AKI biomarkers [TIMP-2]*[IGFBP7]: A single center prospective study (the PREDICTAKI trial).
Vandenberghe W; Van Laethem L; Herck I; Peperstraete H; Schaubroeck H; Zarbock A; Meersch M; Dhondt A; Delanghe S; Vanmassenhove J; De Waele JJ; Hoste EAJ
J Crit Care; 2022 Feb; 67():108-117. PubMed ID: 34741963
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.
Tyagi A; Luthra A; Kumar M; Das S
Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258
[TBL] [Abstract][Full Text] [Related]
32. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
[TBL] [Abstract][Full Text] [Related]
33. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
[TBL] [Abstract][Full Text] [Related]
34. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
[TBL] [Abstract][Full Text] [Related]
35. Urinary Cell-Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury After Ventricular Assist Device Implantation or Cardiac Transplantation.
Alam A; Jamil AK; Van Zyl JS; Medel-Martinez H; Bottiglieri T; Wasek B; Felius J; Lima B; Hall SA; Joseph SM
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2303-2312. PubMed ID: 34774406
[TBL] [Abstract][Full Text] [Related]
36. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
[TBL] [Abstract][Full Text] [Related]
37. Acute kidney injury in critical COVID-19 patients: usefulness of urinary biomarkers and kidney proximal tubulopathy.
Larcher R; Bargnoux AS; Badiou S; Besnard N; Brunot V; Daubin D; Platon L; Benomar R; Amalric M; Dupuy AM; Klouche K; Cristol JP
Ren Fail; 2023; 45(2):2292152. PubMed ID: 38078385
[TBL] [Abstract][Full Text] [Related]
38. Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
Berdugo MA; Kirson NY; Zimmer L; Beyhaghi H; Toback S; Scarpati LM; Stone MN; Dember R; Tseng-Tham J; Wen J; Miller M
J Med Econ; 2019 Dec; 22(12):1281-1289. PubMed ID: 31234668
[No Abstract] [Full Text] [Related]
39. Acute kidney injury biomarkers and hydration assessments following prolonged mild hypohydration in healthy young adults.
Chapman CL; Holt SM; O'Connell CT; Brazelton SC; Howells WAB; Medved HN; Reed EL; Needham KW; Halliwill JR; Minson CT
Am J Physiol Renal Physiol; 2023 Aug; 325(2):F199-F213. PubMed ID: 37318992
[TBL] [Abstract][Full Text] [Related]
40. Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.
Honore PM; Nguyen HB; Gong M; Chawla LS; Bagshaw SM; Artigas A; Shi J; Joannes-Boyau O; Vincent JL; Kellum JA;
Crit Care Med; 2016 Oct; 44(10):1851-60. PubMed ID: 27355527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
